Literature DB >> 31056344

Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Keith A Josephs1, Melissa E Murray2, Nirubol Tosakulwong3, Stephen D Weigand3, David S Knopman4, Ronald C Petersen4, Clifford R Jack5, Jennifer L Whitwell5, Dennis W Dickson2.   

Abstract

INTRODUCTION: Primary age-related tauopathy (PART) is characterized by the presence of neurofibrillary tangles and absent-minimal β-amyloid deposition. Transactive response DNA-binding protein of 43 kDa (TDP-43), a third protein, has recently garnished a lot of attention in Alzheimer's disease where it is associated with memory loss and amygdala and hippocampal atrophy. We aimed to determine whether TDP-43 is associated with brain atrophy in PART.
METHODS: We assessed the frequency of TDP-43 in PART and performed voxel-level analysis in SPM12, as well as region-of-interest analysis using linear regression modeling, controlling for variables of interest, to assess for associations between TDP-43 and brain atrophy.
RESULTS: Of 116 PART cases, 31 (26.7%) had TDP-43. The presence of TDP-43 was associated with significantly greater amygdala, hippocampal, and anterior temporal atrophy in both the region-of-interest and the voxel level analyses. DISCUSSION: TDP-43 is associated with greater brain atrophy in PART.
Copyright © 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrophy; Hippocampus; MRI; PART; TDP-43; Tauopathy

Mesh:

Substances:

Year:  2019        PMID: 31056344      PMCID: PMC6556401          DOI: 10.1016/j.jalz.2019.03.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  51 in total

1.  Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy.

Authors:  Lilah M Besser; John F Crary; Charles Mock; Walter A Kukull
Journal:  Neurology       Date:  2017-09-15       Impact factor: 9.910

2.  Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?

Authors:  J L Whitwell; C R Jack; J E Parisi; M L Senjem; D S Knopman; B F Boeve; R Rademakers; M Baker; R C Petersen; D W Dickson; K A Josephs
Journal:  Neurology       Date:  2010-12-14       Impact factor: 9.910

3.  Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; David S Knopman; Prashanthi Vemuri; Michelle M Mielke; Val Lowe; Matthew L Senjem; Jeffrey L Gunter; Mary M Machulda; Brian E Gregg; V Shane Pankratz; Walter A Rocca; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

Review 4.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

5.  TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.

Authors:  Keith A Josephs; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Amanda M Liesinger; Leonard Petrucelli; Matthew L Senjem; Robert J Ivnik; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson
Journal:  Ann Neurol       Date:  2015-09-16       Impact factor: 10.422

6.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

7.  Differential clinicopathologic and genetic features of late-onset amnestic dementias.

Authors:  Melissa E Murray; Ashley Cannon; Neill R Graff-Radford; Amanda M Liesinger; Nicola J Rutherford; Owen A Ross; Ranjan Duara; Minerva M Carrasquillo; Rosa Rademakers; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-06-05       Impact factor: 17.088

8.  TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD.

Authors:  Sukriti Nag; Lei Yu; Robert S Wilson; Er-Yun Chen; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2017-01-13       Impact factor: 9.910

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Longitudinal patterns of regional change on volumetric MRI in frontotemporal lobar degeneration.

Authors:  Jennifer L Whitwell; Valerie M Anderson; Rachael I Scahill; Martin N Rossor; Nick C Fox
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

View more
  7 in total

1.  Primary age-related tauopathy in a Chinese cohort.

Authors:  Xin Wang; Lei Zhang; Hui Lu; Juan-Li Wu; Hua-Zheng Liang; Chong Liu; Qing-Qing Tao; Zhi-Ying Wu; Ke-Qing Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

2.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

3.  Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.

Authors:  Keith A Josephs; Peter R Martin; Stephen D Weigand; Nirubol Tosakulwong; Marina Buciuc; Melissa E Murray; Leonard Petrucelli; Matthew L Senjem; Anthony J Spychalla; David S Knopman; Bradley F Boeve; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

4.  Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.

Authors:  Robin de Flores; Laura E M Wisse; Sandhitsu R Das; Long Xie; Corey T McMillan; John Q Trojanowski; John L Robinson; Murray Grossman; Edward Lee; David J Irwin; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2020-04-22       Impact factor: 21.566

5.  Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART).

Authors:  Miguel Quintas-Neves; Merilee A Teylan; Lilah Besser; João Soares-Fernandes; Charles N Mock; Walter A Kukull; John F Crary; Tiago Gil Oliveira
Journal:  Acta Neuropathol Commun       Date:  2019-12-09       Impact factor: 7.801

Review 6.  The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.

Authors:  Ito Kawakami; Tetsuaki Arai; Masato Hasegawa
Journal:  Acta Neuropathol       Date:  2019-09-26       Impact factor: 17.088

7.  Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology.

Authors:  V Borghesani; G Battistella; M L Mandelli; A Welch; E Weis; K Younes; J Neuhaus; L T Grinberg; W M Seeley; S Spina; B Miller; Z Miller; M L Gorno-Tempini
Journal:  Neuroimage Clin       Date:  2020-08-06       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.